INCY:NASDAQ
Incyte Corp
$113.12
arrow_upward
+0.33%(+0.38) 1D
Okt 9, 3:34:19 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa INCY...
Buksan
$112.35
Mataas
$113.87
Mababa
$111.80
Mkt. cap
22.93B
Avg. na dami
1.60M
Dami
617.20K
P/E ratio
14.42
Mataas nang 52-wk
$132.58
Mababa nang 52-wk
$82.82
EPS
$7.85
Beta
0.74
Mga natitirang share
202.70M
Bilang ng mga empleyado
3K
Buksan
$112.35
Mataas
$113.87
Mababa
$111.80
Mkt. cap
22.93B
Avg. na dami
1.60M
Dami
617.20K
P/E ratio
14.42
Mataas nang 52-wk
$132.58
Mababa nang 52-wk
$82.82
EPS
$7.85
Beta
0.74
Mga natitirang share
202.70M
Bilang ng mga empleyado
3K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TipRanks
·
2 oras ang nakalipas
Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
Yahoo Finance
·
8 oras ang nakalipas
What to Expect From Incyte’s Next Quarterly Earnings Report
Simply Wall Street
·
16 oras ang nakalipas
Is Rare Disease Approval Altering The Investment Case For Incyte (INCY)?
GuruFocus
·
1 araw ang nakalipas
INCY Maintained by RBC Capital -- Price Target Raised to $114
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Tungkol sa Incyte Corp
CEO-
Mga Empleyado2.84K
Itinatag2002
HeadquartersWilmington, Delaware, Estados Unidos
Sektor-
Websiteincyte.com